Navigate Fool.com
Will PFE beat
the market?



Community Rating: 4 Stars: Favorite

30.34 0.25 (0.83%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.15
Previous Close $30.09
Daily Range $30.07 - $30.38
52-Week Range $27.12 - $32.96
Market Cap $193.7B
P/E Ratio 18.24
Dividend (Yield) $1.04 (3.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 15,889,937
Average Daily Volume 29,222,130
Current FY EPS $2.23

How do you think PFE
will perform against the market?

Top PFE Bull/Bear Pitches


thstorm93 (< 20)
Submitted December 8, 2011

Expiring patents are already priced in so that will have no effect on their stock price. They have a history of creating blockbuster drugs and there are more to come as they currently have 118 drugs … More

0 Replies Reply Report this Post

mcornice1 (< 20)
Submitted December 2, 2010

Not a very well run company. A science company being run by a bunch of businessmen does not produce good results. Sure the dividend and their cash is nice, but I have no confidence that Pfizer can act … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Johnson & Johnson's 3 Major Strengths

What are the three key reasons why J&J could be a top performer in the future?

Roche Reaffirms Full Year Outlook But Suffers From Currency Movements

Pharmaceutical Stocks For Income, Value And Growth Investors

Why Lpath Could Rise 300%

3 Biotech Opportunities Following This Selloff

Here's a second chance to invest in companies with viable growth potential.

The Biggest Biotech Wins of the Week

Find out which biotech and pharmaceutical companies posted the best clinical results for the week ending April 11.

Does Pfizer Offer Good Value?

With a recent P/E ratio in single digits, Pfizer may be the last value play in the pharmaceutical industry.

3 Health Care Stocks Bucking the S&P Downtrend

Health care stocks have been falling hard of late. Have they been dragging broader indices down with them?

Why Is Regeneron Pharmaceuticals, Inc. Bucking the Downtrend?

Last week saw a widespread downturn among biotech stocks. Regeneron Pharmaceuticals, however, was able to move modestly higher. Why?

Biotech Tweet of the Week: Love Being Private

Investors often ignore private biotechs because they can't buy shares, but investors in companies such as InterMune and the obesity drug makers -- Arena Pharmaceuticals, VIVUS, and Orexigen -- need to follow their privately-held competitors.

See More PFE News...





Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks